Abstract:Antidepressants are among the most commonly detected pharmaceuticals in aqueous systems, and, as emerging organic pollutants, may exert negative effects on non-target aquatic organisms. Previously, it has been revealed that antidepressant exposure significantly inhibits the growth and development of fish during their early developmental stages. Thus, in the present study, we aimed to identify and compare the underlying mechanisms of action of different antidepressants at the transcriptional level using zebrafish (Danio rerio) embryos. Through high-throughput RNA sequencing (RNA-Seq) data analysis, 32, 34, and 130 differentially expressed genes (DEGs) were obtained from zebrafish larvae after 120h of embryonic exposure to sublethal concentrations of amitriptyline, fluoxetine, and mianserin, respectively. The expression profiles of the identified DEGs showed similar trends in response to the three antidepressant treatments, suggesting consistent toxic effects of low concentrations of these three drugs on the regulation of gene expression in fish. Several metabolic and signaling pathways, including glycolysis/gluconeogenesis and the insulin pathway, were affected in the exposed fish larvae. The expression profiles of selected DEGs were then verified by the qRT-PCR method, which indicated significant positive correlations with the RNA-Seq results. Next, we determined the concentration-dependent expression patterns of 6 selected DEGs in fish larvae exposed to three antidepressants at a series of environmentally relevant concentrations. The results revealed a significant concentration-dependent reduction in the levels of dual-specificity phosphatase 5 (dusp5) mRNA, as well as a non-concentration-dependent gene expression inhibition of prostaglandin D2 synthase b (ptgdsb); the circadian rhythm-related genes, i.e. those encoding nuclear receptor subfamily 1, group D, member 1 (nr1d1) and period 2 (per2); and genes encoding early growth response factors (egr1 and egr4), in the antidepressant-treated fish larvae. In summary, to our knowledge, our findings demonstrate, for the first time, that the three different categories of antidepressants have common effects on the gene expression involved in multiple biological processes and signaling pathways during the early development of fish and thus provide information for characterizing the adverse outcome pathways and on the ecological risk assessment of these pharmaceutical pollutants in the aquatic environment.

Predicting the potential risks posed by antidepressants as emerging contaminants in fish based on network pharmacological analysis

Antidepressants As Emerging Contaminants: Occurrence in Wastewater Treatment Plants and Surface Waters in Hangzhou, China.

The potential for adverse effects in fish exposed to antidepressants in the aquatic environment

Environmental Occurrence and Predicted Pharmacological Risk to Freshwater Fish of over 200 Neuroactive Pharmaceuticals in Widespread Use

Pollution and Ecotoxicity of Antidepressants in Aquatic Environment

Global Transcriptomic Analysis of Zebrafish in Response to Embryonic Exposure to Three Antidepressants, Amitriptyline, Fluoxetine and Mianserin.

Suppressive immunoregulatory effects of three antidepressants via inhibition of the nuclear factor-κB activation assessed using primary macrophages of carp (Cyprinus carpio)

Risks to aquatic environments posed by 14 pharmaceuticals as illustrated by their effects on zebrafish behaviour

Construction of an antidepressant priority list based on functional, environmental, and health risks using an interpretable mixup-transformer deep learning model

Medicating the coast in a metropolitan city: Enantiomeric profiles and joint probabilistic risk assessment of antidepressants and antihistamines

Antidepressants as Endocrine Disrupting Compounds in Fish

Biological-Activity-Based Prioritization of Antidepressants in Wastewater in England and Japan

Toxicity of waterborne vortioxetine, a new antidepressant, in non-target aquatic organisms: From wonder to concern drugs?

Occurrence and fate of antidepressants in the aquatic environment: Insights into toxicological effects on the aquatic life, analytical methods, and removal techniques

Pharmaceutical Compounds in Aquatic Environment in China: Locally Screening and Environmental Risk Assessment

Environmentally Relevant Concentrations of Antidepressant Mirtazapine Impair the Neurodevelopment of Zebrafish (danio Rerio)

Low doses and lifecycle exposure of waterborne antidepressants in zebrafish model: A survey on sperm traits, reproductive behaviours, and transcriptome responses

Network pharmacology screening, in vitro and in vivo evaluation of antianxiety and antidepressant drug-food analogue

Effects of the antidepressant, mianserin, on early development of fish embryos at low environmentally relevant concentrations.

Simultaneous Occurrence of Psychotropic Pharmaceuticals in Surface Water of the Megacity Shanghai and Implication for Their Ecotoxicological Risks

Predicting environmental risks of pharmaceutical residues by wastewater surveillance: An analysis based on pharmaceutical sales and their excretion data